Where the label starts you on the new medication, and why no equipotency conversion between these drugs exists.
Read this first. There is no published equipotency between semaglutide, tirzepatide and liraglutide. No conversion table exists because the trials that would produce one have not been run. What this page shows is where the label starts each drug, and what prescribers commonly do when someone moves across. It is not a dose recommendation and it is not a substitute for the conversation with the person writing your prescription.
The dose you are on now, not the one you are aiming for.
These are the label's steps. Prescribers hold people longer at a step all the time, usually for tolerability. Moving faster than this is what produces the nausea stories.
People expect a chart that says 1 mg of semaglutide equals some number of milligrams of tirzepatide. That chart does not exist, and the reason is not laziness.
Semaglutide is a GLP-1 receptor agonist. Tirzepatide acts on GLP-1 and GIP receptors. They are not the same drug at different strengths, they are different mechanisms with different side effect profiles and different tolerability curves in the same person. A dose you tolerate well on one can be miserable on the other, in either direction.
Head-to-head trials measured outcomes, not dose equivalence. Nobody has run the study that would let anyone publish a conversion, so anyone who hands you one made it up.
Most prescribers restart the new drug at its label starting dose and titrate up from there, regardless of where you were on the old one. It is slower and it is frustrating if you were already at a high dose, but it is the approach with the safety data behind it.
Some prescribers will begin a step above the lowest for someone who was tolerating a high dose of the previous drug with no significant gastrointestinal effects. This is a clinical judgement about your specific history. It is not something to decide from a web page, and it is not something a compounding pharmacy can decide for you either.
If several weeks passed between the last dose of the old drug and the first of the new one, the tolerance you built is gone. Prescribers generally treat a long gap as starting fresh.
Both weekly drugs are once a week on any day you pick, so a switch is a natural moment to move to a day that suits you better. Moving to Saxenda means moving to daily injections, which is a bigger change in routine than people expect.
Different concentrations, different pen sizes, different refill intervals. Recalculate what you need with the supply calculator before you run out mid-switch.
The nausea that faded on your old medication may return at the start of the new one, because the adaptation is drug-specific. This is expected and usually temporary.
GLPme logs every shot, remembers your titration schedule, warns you before you run out of medication, and shows your weight trend against your goal. Core tracking is free.